Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The prospective evaluation of the effect of thromboprophylaxis in women with one unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of 160 patients with heterozygous factor V Leiden mutation, prothrombin G20210A mutation, or protein S deficiency were given 5 mg folic acid daily before conception, to be continued during pregnancy, and low-dose aspirin 100 mg daily or low-molecular-weight heparin enoxaparin 40 mg was taken from the 8th week. Twenty-three of the 80 patients treated with low-dose aspirin and 69 of the 80 patients treated with enoxaparin had a healthy live birth (odds ratio [OR], 15.5; 95% confidence interval [CI], 7-34, P < .0001). Enoxaparin was superior to low-dose aspirin in each subgroup defined according to the underlying constitutional thrombophilic disorder. An associated protein Z deficiency and/or positive antiprotein Z antibodies were associated with poorer outcomes. The neonate weight was higher in the women successfully treated with enoxaparin, and neonates small for gestational age were more frequent in patients treated with low-dose aspirin. No significant side effects of the treatments could be evidenced in patients or newborns. As there is no argument to prove that low-dose aspirin may have been deleterious, these results support enoxaparin use during such at-risk pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One prospective randomised trial demonstrated the efficacy of LMWH for the treatment of women with a history of a single late miscarriage after 10 weeks of gestation who have the Factor V Leiden or prothrombin gene mutation or have protein S deficiency.The live birth rate in women treated with enoxaparin was 86% compared with 29% in women taking low dose aspirin alone (OR 15.5, 95% CI 7-34).178”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [178]
Citations
Cites
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Fetal programming of coronary heart disease
BARKER, D. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00689-6 · Cited by 678
Li, D.-K., Liu, L., & Odouli, R. (2003) · BMJ · doi:10.1136/bmj.327.7411.368 · Cited by 434
Gestational Outcome in Thrombophilic Women with Recurrent Pregnancy Loss Treated by Enoxaparin
Hoffman, R., Blumenfeld, Z., Weiner, Z., Younis, J. S., & Brenner, B. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613894 · Cited by 283
The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women
Jan Sanson, B., Friedrich, P. W., Simioni, P., Zanardi, S., Huisman, M. V., Girolami, A., Wouter ten Cate, J., & Prins, M. H. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650282 · Cited by 220
Gris, J., Quéré, I., Monpeyroux, F., Mercier, É., Ripart-Neveu, S., Tailland, M.-L., Hoffet, M., Berlan, J., Daurès, J., & Marès, P. (1999) · PubMed · Cited by 207
Self-citationCarp, H., Dolitzky, M., & Inbal, A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00066.x · Cited by 191
Quéré, I., Monpeyrou, F., Mercier, E., Ripart-Neveu, S., Tailland, M.-L., Hoffet, M., Berlan, J., Daurès, J.-P., Marès, P., & Gris, J.-C. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614594 · Cited by 178
Self-citationQuéré, I., Sanmarco, M., Boutière, B., Mercier, É., Amiral, J., Hubert, A.-M., Ripart-Neveu, S., Hoffet, M., Tailland, M.-L., Rousseau, O., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614001 · Cited by 156
Self-citationProthrombotic phenotype of protein Z deficiency
Yin, Z.-F., Huang, Z.-F., Cui, J., Fiehler, R., Lasky, N., Ginsburg, D., & Broze, G. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120081897 · Cited by 155
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Thrombophilia in pregnancy: a systematic review
Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G. D. O., Walker, I. D., Greaves, M., Brenkel, I., Regan, L., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05847.x · Cited by 849
“In one study, low-dose aspirin and LMW heparin were compared in women with a single unexplained fetal loss from the 10th week of pregnancy (Gris et al, 2004).”
BackgroundMethodGreer, I. A., & Nelson-Piercy, C. (2005) · Blood · doi:10.1182/blood-2005-02-0626 · Cited by 797
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Greaves, M., Walker, I., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489
Metadata
- Authors
- Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P.
- Affiliations
- Centre Hospitalier Universitaire de Nîmes (FR)
- From the Hematology Laboratory, University Hospital, Nîmes, France; the Department of Gynecology and Obstetrics, University Hospital, Nîmes, France; the Hematology Laboratory, Montpellier 1 University, Montpellier; France; and the Equipe d'Accueil 2992, Montpellier 1 University, Montpellier; France.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 3695-3699
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2036030218
- Cited by
- 397
- References
- 25
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 18 · 2016: 15 · 2015: 16 · 2014: 25 · 2013: 18 · 2012: 18
- FWCI
- 27.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- low molecular weight heparin, enoxaparin, low-dose aspirin, thromboprophylaxis, recurrent pregnancy loss, thrombophilia, factor V Leiden, prothrombin G20210A, protein S deficiency, protein Z deficiency, folic acid supplementation, live birth rate, birth weight, small for gestational age
- MeSH terms
- Aspirin, Birth Weight, Female, Fetal Death, Folic Acid, Heparin, Low-Molecular-Weight, Humans, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Odds Ratio, Enoxaparin, Thrombophilia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. https://app.cochat.ai/papers/10.1182/blood-2003-12-4250
- The paper
- Gris, J.-C., Mercier, E., Quéré, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.-L., Dauzat, M., & Marès, P. (2004). Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. https://doi.org/10.1182/blood-2003-12-4250
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.